Association between Genetic Variation in the Oxytocin Receptor Gene and Emotional Withdrawal, but not between Oxytocin Pathway Genes and Diagnosis in Psychotic Disorders

Social dysfunction is common in patients with psychotic disorders. Oxytocin is a neuropeptide with a central role in social behavior. This study aims to explore the relationship between oxytocin pathway genes and symptoms related to social dysfunction in patients with psychotic disorders. We performed association analyses between four oxytocin pathway genes (OXT, OXTR, AVP, and CD38) and four areas of social behavior-related psychopathology as measured by Positive and Negative Syndrome Scale. For this purpose, we used both a polygenic risk score (PGRS) and single OXTR candidate single nucleotide polymorphism previously reported in the literature (rs53576, rs237902, and rs2254298). A total of 734 subjects with DSM-IV psychotic spectrum disorders and 420 healthy controls were included. Oxytocin pathway PGRSs were calculated based on the independent Psychiatric Genomics Consortium study sample. There was a significant association between symptom of Emotional Withdrawal and the previously reported OXTR risk allele A in rs53576. No significant associations between oxytocin pathway gene variants and a diagnosis of psychotic disorder were found. Our findings indicate that while oxytocin pathway genes do not appear to contribute to the susceptibility to psychotic disorders, variations in the OXTR gene might play a role in the development of impaired social behavior.

[1]  G. Pearlson,et al.  Reduced levels of vasopressin and reduced behavioral modulation of oxytocin in psychotic disorders. , 2014, Schizophrenia bulletin.

[2]  S. Djurovic,et al.  Polygenic risk score and the psychosis continuum model , 2014, Acta psychiatrica Scandinavica.

[3]  S. Marder,et al.  Psychopharmacology of the negative symptoms: Current status and prospects for progress , 2014, European Neuropsychopharmacology.

[4]  Thomas Steckler,et al.  Negative symptoms of schizophrenia: Clinical characteristics, pathophysiological substrates, experimental models and prospects for improved treatment , 2014, European Neuropsychopharmacology.

[5]  M. Bakermans-Kranenburg,et al.  A sociability gene? Meta-analysis of oxytocin receptor genotype effects in humans , 2014, Psychiatric genetics.

[6]  M. Glymour,et al.  Are genetic variations in OXTR, AVPR1A, and CD38 genes important to social integration? Results from two large U.S. cohorts , 2014, Psychoneuroendocrinology.

[7]  Kenneth Hugdahl,et al.  Working memory networks and activation patterns in schizophrenia and bipolar disorder: comparison with healthy controls , 2014, British Journal of Psychiatry.

[8]  L. Goossens,et al.  The Oxytocin Receptor Gene (OXTR) in Relation to State Levels of Loneliness in Adolescence: Evidence for Micro-Level Gene-Environment Interactions , 2013, PloS one.

[9]  D. Rujescu,et al.  Oxytocin and oxytocin receptor gene polymorphisms and risk for schizophrenia: A case–control study , 2013, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[10]  S. Shamay-Tsoory,et al.  Characterization of the effects of oxytocin on fear recognition in patients with schizophrenia and in healthy controls , 2013, Front. Neurosci..

[11]  Helena M Service,et al.  Differential correlations between plasma oxytocin and social cognitive capacity and bias in schizophrenia , 2013, Schizophrenia Research.

[12]  R. Parasuraman,et al.  Oxytocin selectively increases perceptions of harm for victims but not the desire to punish offenders of criminal offenses. , 2013, Social cognitive and affective neuroscience.

[13]  C. Carter,et al.  Peripheral vasopressin but not oxytocin relates to severity of acute psychosis in women with acutely-ill untreated first-episode psychosis , 2013, Schizophrenia Research.

[14]  M. Brüne,et al.  Improving social perception in schizophrenia: The role of oxytocin , 2013, Schizophrenia Research.

[15]  Brian A. Nosek,et al.  Power failure: why small sample size undermines the reliability of neuroscience , 2013, Nature Reviews Neuroscience.

[16]  D. Kelly,et al.  Effects of adjunctive intranasal oxytocin on olfactory identification and clinical symptoms in schizophrenia: Results from a randomized double blind placebo controlled pilot study , 2013, Schizophrenia Research.

[17]  D. Rujescu,et al.  Improved Detection of Common Variants Associated with Schizophrenia and Bipolar Disorder Using Pleiotropy-Informed Conditional False Discovery Rate , 2013, PLoS genetics.

[18]  J. O. Johannessen,et al.  Is there an optimal factor structure of the Positive and Negative Syndrome Scale in patients with first-episode psychosis? , 2013, Scandinavian journal of psychology.

[19]  M. McCarthy,et al.  Improved detection of common variants associated with schizophrenia by leveraging pleiotropy with cardiovascular-disease risk factors. , 2013, American journal of human genetics.

[20]  Robert Kumsta,et al.  Oxytocin, stress and social behavior: neurogenetics of the human oxytocin system , 2013, Current Opinion in Neurobiology.

[21]  H. Higashida,et al.  The Roles of Oxytocin and CD38 in Social or Parental Behaviors , 2013, Front. Neurosci..

[22]  M. Bakermans-Kranenburg,et al.  Oxytocin in postnatally depressed mothers: Its influence on mood and expressed emotion , 2013, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[23]  S. Kidd From Social Experience to Illness Experience: Reviewing the Psychological Mechanisms Linking Psychosis with Social Context , 2013, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[24]  Jürgen Gallinat,et al.  Association between Oxytocin Receptor Gene Polymorphisms and Self-Rated ‘Empathic Concern’ in Schizophrenia , 2012, PloS one.

[25]  Yuichiro Watanabe,et al.  Oxytocin receptor (OXTR) gene and risk of schizophrenia: Case–control and family‐based analyses and meta‐analysis in a Japanese population , 2012, Psychiatry and clinical neurosciences.

[26]  I. Melle,et al.  Is cognitive impairment following early life stress in severe mental disorders based on specific or general cognitive functioning? , 2012, Psychiatry Research.

[27]  B. Lerer,et al.  Oxytocin and vasopressin genes are significantly associated with schizophrenia in a large Arab-Israeli pedigree. , 2012, The international journal of neuropsychopharmacology.

[28]  R. Joober,et al.  Coping style moderates the effect of intranasal oxytocin on the mood response to interpersonal stress. , 2012, Experimental and clinical psychopharmacology.

[29]  J. Read,et al.  Childhood Adversities Increase the Risk of Psychosis: A Meta-analysis of Patient-Control, Prospective- and Cross-sectional Cohort Studies , 2012, Schizophrenia bulletin.

[30]  Sohye Kim,et al.  Maternal oxytocin response during mother–infant interaction: Associations with adult temperament , 2012, Hormones and Behavior.

[31]  D. Penn,et al.  Intranasal oxytocin reduces psychotic symptoms and improves Theory of Mind and social perception in schizophrenia , 2011, Schizophrenia Research.

[32]  M. Swami New from NPG: Genome-wide association study identifies five new schizophrenia loci , 2011, Nature Medicine.

[33]  B. Levy,et al.  Functional Outcome in Bipolar Disorder: The Big Picture , 2011, Depression research and treatment.

[34]  S. Schmidt,et al.  Social cognition as a mediator variable between neurocognition and functional outcome in schizophrenia: empirical review and new results by structural equation modeling. , 2011, Schizophrenia bulletin.

[35]  Peter Kirsch,et al.  Oxytocin and vasopressin in the human brain: social neuropeptides for translational medicine , 2011, Nature Reviews Neuroscience.

[36]  J. Buitelaar,et al.  Long-term efficacy and safety outcomes with OROS-MPH in adults with ADHD , 2011, The international journal of neuropsychopharmacology.

[37]  Olivier Luminet,et al.  Personality-dependent effects of oxytocin: Greater social benefits for high alexithymia scorers , 2011, Biological Psychology.

[38]  N. Bolger,et al.  Social effects of oxytocin in humans: context and person matter , 2011, Trends in Cognitive Sciences.

[39]  A. Minassian,et al.  Adjunctive Intranasal Oxytocin Reduces Symptoms in Schizophrenia Patients , 2010, Biological Psychiatry.

[40]  Elvira Bramon,et al.  Gene variants associated with schizophrenia in a Norwegian genome-wide study are replicated in a large European cohort. , 2010, Journal of psychiatric research.

[41]  A. Reichenberg,et al.  The assessment of neuropsychological functioning in schizophrenia , 2010, Dialogues in clinical neuroscience.

[42]  Shelley E. Taylor,et al.  Culture, distress, and oxytocin receptor polymorphism (OXTR) interact to influence emotional support seeking , 2010, Proceedings of the National Academy of Sciences.

[43]  H. Meltzer,et al.  Variants in the oxytocin gene and risk for schizophrenia , 2010, Schizophrenia Research.

[44]  Daniel R. Weinberger,et al.  A common allele in the oxytocin receptor gene (OXTR) impacts prosocial temperament and human hypothalamic-limbic structure and function , 2010, Proceedings of the National Academy of Sciences.

[45]  C. Viero,et al.  REVIEW: Oxytocin: Crossing the Bridge between Basic Science and Pharmacotherapy , 2010, CNS neuroscience & therapeutics.

[46]  Anders M. Dale,et al.  CORTICAL THICKNESS AND SUBCORTICAL VOLUMES IN SCHIZOPHRENIA AND BIPOLAR DISORDER , 2010, Schizophrenia Research.

[47]  M. Gill,et al.  Evidence that genetic variation in the oxytocin receptor (OXTR) gene influences social cognition in ADHD , 2010, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[48]  N. Craddock,et al.  Genetics of bipolar disorder. , 2010, Journal of medical genetics.

[49]  K. Macdonald,et al.  The peptide that binds: a systematic review of oxytocin and its prosocial effects in humans. , 2010, Harvard review of psychiatry.

[50]  Oliver P. John,et al.  Oxytocin receptor genetic variation relates to empathy and stress reactivity in humans , 2009, Proceedings of the National Academy of Sciences.

[51]  P. Visscher,et al.  Common polygenic variation contributes to risk of schizophrenia and bipolar disorder , 2009, Nature.

[52]  Henry Völzke,et al.  Associations between the oxytocin receptor gene (OXTR) and affect, loneliness and intelligence in normal subjects , 2009, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[53]  Imre Kiss,et al.  Sharing secrets: Oxytocin and trust in schizophrenia , 2009, Social neuroscience.

[54]  M. Bakermans-Kranenburg,et al.  Oxytocin receptor (OXTR) and serotonin transporter (5-HTT) genes associated with observed parenting. , 2008, Social cognitive and affective neuroscience.

[55]  M. Cox,et al.  Parenting quality, DRD4, and the prediction of externalizing and internalizing behaviors in early childhood. , 2007, Developmental psychobiology.

[56]  Jennifer A. Bartz,et al.  CD38 regulates oxytocin secretion and complex social behavior. , 2007, BioEssays : news and reviews in molecular, cellular and developmental biology.

[57]  Eden R Martin,et al.  No gene is an island: the flip-flop phenomenon. , 2007, American journal of human genetics.

[58]  T. Seike,et al.  CD38 is critical for social behaviour by regulating oxytocin secretion , 2007, Nature.

[59]  J. Addington,et al.  Influence of social perception and social knowledge on cognitive and social functioning in early psychosis , 2006, British Journal of Psychiatry.

[60]  Jing Liu,et al.  Positive Association of the Oxytocin Receptor Gene (OXTR) with Autism in the Chinese Han Population , 2005, Biological Psychiatry.

[61]  U. Fischbacher,et al.  Oxytocin increases trust in humans , 2005, Nature.

[62]  Melissa J. Green,et al.  Social threat perception and the evolution of paranoia , 2004, Neuroscience & Biobehavioral Reviews.

[63]  T. Insel,et al.  Oxytocin in the Medial Amygdala is Essential for Social Recognition in the Mouse , 2001, The Journal of Neuroscience.

[64]  T. Insel,et al.  The neurobiology of attachment , 2001, Nature Reviews Neuroscience.

[65]  W. Bujanow Hormones in the treatment of psychoses. , 1972, British medical journal.

[66]  B. M. Reddy,et al.  Current status of understanding of the genetic etiology of coronary heart disease. , 2013, Journal of postgraduate medicine.

[67]  S. Akhondzadeh,et al.  Intranasal Oxytocin as an Adjunct to Risperidone in Patients with Schizophrenia , 2012, CNS Drugs.

[68]  I. Melle,et al.  Neurocognitive dysfunction in bipolar and schizophrenia spectrum disorders depends on history of psychosis rather than diagnostic group. , 2011, Schizophrenia bulletin.

[69]  B. Christensen,et al.  Social cognition mediates illness-related and cognitive influences on social function in patients with schizophrenia-spectrum disorders. , 2010, Journal of psychiatry & neuroscience : JPN.

[70]  G. Guillon,et al.  Peptide and non-peptide agonists and antagonists for the vasopressin and oxytocin V1a, V1b, V2 and OT receptors: research tools and potential therapeutic agents. , 2008, Progress in brain research.

[71]  S. Kay,et al.  The positive and negative syndrome scale (PANSS) for schizophrenia. , 1987, Schizophrenia bulletin.